Literature DB >> 17298450

Increased surfactant protein-D and foamy macrophages in smoking-induced mouse emphysema.

Noriyuki Hirama1, Yoko Shibata, Kazuhisa Otake, Jun-ichi Machiya, Toshihiro Wada, Sumito Inoue, Shuichi Abe, Noriaki Takabatake, Makoto Sata, Isao Kubota.   

Abstract

BACKGROUND AND
OBJECTIVE: The molecular mechanisms underlying COPD remain undetermined. The lungs of surfactant protein-D (SP-D) deficient mice show emphysema and an excessive number of foamy macrophages. This study aims to elucidate roles of SP-D and foamy macrophages in smoking-induced mouse emphysema.
METHODS: Twenty B6C3F1 mice were exposed to cigarette smoke (2 cigarettes/day/mouse for 6 months). The mice were killed, and formalin-fixed, paraffin-embedded lung sections were carried out on seven mice, BAL was carried out on six mice, and seven mice were used to make lung homogenates. In in vitro studies, A549 cells were transduced with the SP-D expression plasmid and treated with cigarette smoke extract to evaluate cell viability.
RESULTS: Emphysema was induced in the mice by chronic cigarette smoke exposure. Increased expression of matrix metalloproteinase-9 and -12 was observed, and foamy alveolar macrophages accumulated in the smoke-exposed lungs. Immunostaining of BAL cells revealed the major source of matrix metalloproteinase-12 to be foamy alveolar macrophages. Furthermore, SP-D was elevated in emphysema lungs. Expression of transcription factors, Fra-1, junB and C/EBPbeta (which induce SP-D) were significantly elevated in emphysema lungs. The in vitro expression of SP-D gene in A549 cells prolonged cell survival following exposure to cigarette smoke condensate.
CONCLUSIONS: The accumulation of foamy alveolar macrophages may play a key role in the development of smoking-induced emphysema. Increased SP-D may play a protective role in the development of smoking-induced emphysema, in part by preventing alveolar cell death.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17298450     DOI: 10.1111/j.1440-1843.2006.01009.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  17 in total

1.  Serum pneumoproteins in tunnel construction workers.

Authors:  Dag G Ellingsen; Bente Ulvestad; Berit Bakke; Ingebjørg Seljeflot; Lars Barregard; Yngvar Thomassen
Journal:  Int Arch Occup Environ Health       Date:  2015-01-30       Impact factor: 3.015

2.  Lung surfactant protein D (SP-D) response and regulation during acute and chronic lung injury.

Authors:  Maria Quisgaard Gaunsbaek; Karina Juhl Rasmussen; Michael F Beers; Elena N Atochina-Vasserman; Soren Hansen
Journal:  Lung       Date:  2013-02-24       Impact factor: 2.584

3.  Oxidized phospholipid, 1-palmitoyl-2-(9'-oxo-nonanoyl)-glycerophosphocholine (PON-GPC), produced in the lung due to cigarette smoking, impairs immune function in macrophages.

Authors:  Tomomi Kimura; Yoko Shibata; Keiko Yamauchi; Akira Igarashi; Sumito Inoue; Shuichi Abe; Kazuhiro Fujita; Yoichi Uosaki; Isao Kubota
Journal:  Lung       Date:  2011-10-11       Impact factor: 2.584

4.  Serum Surfactant Protein Levels in Patients Admitted to the Hospital with Acute COPD Exacerbation.

Authors:  Andriana I Papaioannou; Elisavet Konstantelou; Anastasia Papaporfyriou; Konstantinos Bartziokas; Aris Spathis; Petros Bakakos; Stelios Loukides; Nikolaos Koulouris; Spyros Papiris; Konstantinos Kostikas
Journal:  Lung       Date:  2018-02-14       Impact factor: 2.584

5.  Targeted Disruption of Ig-Hepta/Gpr116 Causes Emphysema-like Symptoms That Are Associated with Alveolar Macrophage Activation.

Authors:  Donna Maretta Ariestanti; Hikaru Ando; Shigehisa Hirose; Nobuhiro Nakamura
Journal:  J Biol Chem       Date:  2015-03-16       Impact factor: 5.157

6.  Myeloid-specific Fos-related antigen-1 regulates cigarette smoke-induced lung inflammation, not emphysema, in mice.

Authors:  Michelle Vaz; Subbiah Rajasekaran; Haranatha R Potteti; Sekhar P Reddy
Journal:  Am J Respir Cell Mol Biol       Date:  2015-07       Impact factor: 6.914

7.  A critical role for ABC transporters in persistent lung inflammation in the development of emphysema after smoke exposure.

Authors:  Jarrod Sonett; Monica Goldklang; Piotr Sklepkiewicz; Adam Gerber; Jordis Trischler; Tina Zelonina; Marit Westerterp; Vincent Lemaître; Yasunori Okada; Jeanine D'Armiento
Journal:  FASEB J       Date:  2018-06-15       Impact factor: 5.191

8.  A Fra-1-dependent, matrix metalloproteinase driven EGFR activation promotes human lung epithelial cell motility and invasion.

Authors:  Pavan Adiseshaiah; Michelle Vaz; Narsa Machireddy; Dhananjaya V Kalvakolanu; Sekhar P Reddy
Journal:  J Cell Physiol       Date:  2008-08       Impact factor: 6.384

9.  Smoking reduces surfactant protein D and phospholipids in patients with and without chronic obstructive pulmonary disease.

Authors:  Jayaji M Moré; Dennis R Voelker; Lori J Silveira; Michael G Edwards; Edward D Chan; Russell P Bowler
Journal:  BMC Pulm Med       Date:  2010-10-25       Impact factor: 3.317

10.  ERK signaling regulates tumor promoter induced c-Jun recruitment at the Fra-1 promoter.

Authors:  Pavan Adiseshaiah; Jinfang Li; Michelle Vaz; Dhananjaya V Kalvakolanu; Sekhar P Reddy
Journal:  Biochem Biophys Res Commun       Date:  2008-04-22       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.